by Sue Brown, CEO ARMA
This will be my last blog for this newsletter as I step down from the CEO role. Inevitably I’m reflecting on how things have changed in the over 8 years I’ve been in the role.
The position of MSK in NHS England and NHS Wales is stronger. In England we now have a co-ordinated workstream under GIRFT delivering across the spectrum of MSK – children and adults, primary, secondary and community, all MSK conditions. The resource is nothing like other NHS England programmes such as diabetes or cancer.…
Read more of this article